Hologic Company Insiders
HOLX Stock | USD 64.16 0.17 0.27% |
Hologic employs about 7.1 K people. The company is managed by 23 executives with a total tenure of roughly 42 years, averaging almost 1.0 years of service per executive, having 307.09 employees per reported executive. Break down of Hologic's management performance can provide insight into the company performance.
Stephen MacMillan Chairman Chairman, CEO and Pres |
Jan Verstreken President Regional President - Europe,Middle EastandAfrica(EMEA) and Canada |
Insider Sentiment 50
Impartial
Selling | Buying |
Latest Trades
2025-06-26 | Ro Khanna | Disposed @ 65.11 | |||
2025-05-09 | Ro Khanna | Acquired @ 56.74 | |||
2025-05-08 | Ro Khanna | Acquired @ 56.18 | |||
2025-05-07 | Martin D Madaus | Acquired 5445 @ 55.24 | View | ||
2025-05-02 | Ro Khanna | Acquired @ 54.16 | |||
2025-04-09 | Ro Khanna | Acquired @ 59.31 | |||
2025-03-31 | Gilbert Ray Cisneros, Jr. | Disposed @ 61.77 | |||
2024-12-04 | Essex D Mitchell | Disposed 24856 @ 76.34 | View | ||
2024-08-06 | Brandon Schnittker | Disposed 476 @ 83.11 | View | ||
2024-08-01 | Benjamin Jordan Cohn | Disposed 5093 @ 81.99 | View |
Monitoring Hologic's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Hologic's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Hologic. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Hologic's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. Hologic's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Hologic's future performance. Based on our forecasts, it is anticipated that Hologic will maintain a workforce of slightly above 7060 employees by August 2025.Hologic's latest congressional trading
Congressional trading in companies like Hologic, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Hologic by those in governmental positions are based on the same information available to the general public.
2025-04-08 | Representative Gilbert Cisneros | Acquired Under $15K | Verify | ||
2023-02-02 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
2023-02-01 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
2018-12-12 | Senator John Reed | Acquired Under $15K | Verify |
Hologic Management Team Effectiveness
The company has return on total asset (ROA) of 0.0692 % which means that it generated a profit of $0.0692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1177 %, meaning that it created $0.1177 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hologic's Return On Tangible Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.1 in 2025, whereas Return On Capital Employed is likely to drop 0.08 in 2025. At this time, Hologic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 4.6 B in 2025, whereas Non Current Assets Total are likely to drop slightly above 3.1 B in 2025.Net Income Applicable To Common Shares is likely to rise to about 550.6 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 170.5 M in 2025.
Hologic Workforce Comparison
Hologic is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 194,234. Hologic holds roughly 7,063 in number of employees claiming about 4% of equities under Health Care industry.
Hologic Profit Margins
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.39 | 0.514 |
|
| |||||
Net Profit Margin | 0.12 | 0.1131 |
|
| |||||
Operating Profit Margin | 0.17 | 0.1658 |
|
| |||||
Pretax Profit Margin | 0.18 | 0.1678 |
|
| |||||
Return On Assets | 0.0353 | 0.0499 |
|
| |||||
Return On Equity | 0.0954 | 0.0909 |
|
|
Hologic Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Hologic insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.9063 | 29 | 32 | 568,425 | 171,418 |
2024-09-01 | 0.3846 | 5 | 13 | 89,555 | 204,553 |
2024-03-01 | 1.4286 | 20 | 14 | 81,895 | 104,615 |
2023-12-01 | 0.675 | 27 | 40 | 408,829 | 270,502 |
2023-09-01 | 1.0 | 2 | 2 | 2,886 | 1,064,954 |
2023-03-01 | 3.8 | 19 | 5 | 55,563 | 19,973 |
2022-12-01 | 0.6087 | 28 | 46 | 606,506 | 497,617 |
2022-06-01 | 0.3333 | 3 | 9 | 10,896 | 33,680 |
2022-03-01 | 16.0 | 16 | 1 | 66,048 | 2,179 |
2021-12-01 | 0.9565 | 22 | 23 | 709,494 | 142,271 |
2021-09-01 | 0.4 | 2 | 5 | 31,683 | 63,717 |
2021-03-01 | 5.0 | 15 | 3 | 54,127 | 22,892 |
2020-12-01 | 0.6977 | 30 | 43 | 1,394,986 | 694,422 |
2020-09-01 | 0.25 | 3 | 12 | 23,447 | 95,855 |
2020-06-01 | 0.5833 | 7 | 12 | 279,980 | 537,160 |
2020-03-01 | 1.5 | 21 | 14 | 338,419 | 513,160 |
2019-12-01 | 0.8065 | 25 | 31 | 682,229 | 500,257 |
2019-09-01 | 0.1667 | 2 | 12 | 223,762 | 485,005 |
2019-03-01 | 2.5714 | 18 | 7 | 82,125 | 44,136 |
2018-12-01 | 0.8537 | 35 | 41 | 656,768 | 246,967 |
2018-09-01 | 0.1429 | 2 | 14 | 16,694 | 108,953 |
2018-06-01 | 0.6 | 6 | 10 | 31,245 | 48,230 |
2018-03-01 | 2.2222 | 20 | 9 | 93,218 | 28,142 |
2017-12-01 | 1.0851 | 51 | 47 | 1,997,456 | 682,613 |
2017-09-01 | 0.3077 | 4 | 13 | 18,200 | 76,626 |
2017-06-01 | 0.6119 | 41 | 67 | 338,886 | 502,654 |
2017-03-01 | 1.0526 | 40 | 38 | 406,575 | 425,226 |
2016-12-01 | 0.9375 | 45 | 48 | 1,081,473 | 605,813 |
2016-09-01 | 0.6 | 6 | 10 | 38,521 | 68,992 |
2016-06-01 | 0.5263 | 10 | 19 | 76,009 | 119,993 |
2016-03-01 | 2.0588 | 35 | 17 | 162,758 | 60,169 |
2015-12-01 | 0.9474 | 36 | 38 | 522,261 | 192,212 |
2015-09-01 | 0.5862 | 17 | 29 | 372,964 | 6,705,928 |
2015-06-01 | 0.3864 | 17 | 44 | 112,618 | 273,029 |
2015-03-01 | 1.7917 | 43 | 24 | 363,246 | 272,609 |
2014-12-01 | 1.0789 | 41 | 38 | 921,812 | 148,788 |
2014-09-01 | 0.6 | 3 | 5 | 52,392 | 60,038 |
2014-06-01 | 0.75 | 21 | 28 | 599,638 | 635,118 |
2014-03-01 | 3.5 | 28 | 8 | 790,442 | 329,493 |
2013-12-01 | 0.8451 | 60 | 71 | 38,847,284 | 67,825,212 |
2013-09-01 | 0.2143 | 9 | 42 | 532,487 | 2,076,099 |
2013-06-01 | 0.5 | 4 | 8 | 80,807 | 135,558 |
2013-03-01 | 1.1481 | 31 | 27 | 406,147 | 964,629 |
2012-12-01 | 0.5102 | 25 | 49 | 1,101,677 | 320,004 |
2012-09-01 | 0.5217 | 12 | 23 | 506,846 | 736,633 |
2012-06-01 | 0.5714 | 4 | 7 | 75,000 | 103,985 |
2012-03-01 | 1.2222 | 22 | 18 | 237,525 | 238,014 |
2011-12-01 | 0.7059 | 24 | 34 | 1,152,764 | 360,740 |
2011-06-01 | 0.5 | 3 | 6 | 159,308 | 425,308 |
2011-03-01 | 0.2895 | 11 | 38 | 97,805 | 372,784 |
2010-12-01 | 0.6667 | 14 | 21 | 367,215 | 54,580 |
2010-03-01 | 0.5 | 8 | 16 | 73,282 | 440,658 |
2009-12-01 | 0.7143 | 15 | 21 | 674,328 | 165,413 |
2009-09-01 | 0.5 | 3 | 6 | 315,000 | 630,000 |
2009-06-01 | 1.6 | 8 | 5 | 103,138 | 146,000 |
2009-03-01 | 0.6667 | 4 | 6 | 49,150 | 174,000 |
2008-12-01 | 12.0 | 12 | 1 | 1,193,000 | 27,005 |
2008-06-01 | 3.5 | 7 | 2 | 20,000 | 19,901 |
2008-03-01 | 3.0 | 18 | 6 | 726,005 | 94,000 |
2007-12-01 | 1.0968 | 136 | 124 | 6,743,287 | 4,154,401 |
2007-03-01 | 0.6842 | 13 | 19 | 637,500 | 1,253,000 |
2006-12-01 | 1.0 | 6 | 6 | 21,694 | 42,000 |
2006-03-01 | 1.0 | 3 | 3 | 26,000 | 45,000 |
2005-12-01 | 0.7273 | 8 | 11 | 83,500 | 157,000 |
2005-09-01 | 1.0 | 4 | 4 | 49,000 | 48,000 |
2005-06-01 | 0.6667 | 2 | 3 | 6,250 | 12,500 |
2005-03-01 | 0.625 | 20 | 32 | 339,750 | 759,570 |
2004-12-01 | 1.3333 | 8 | 6 | 90,500 | 23,500 |
2004-09-01 | 1.2 | 6 | 5 | 93,906 | 20,562 |
2004-03-01 | 1.0 | 12 | 12 | 48,565 | 42,627 |
Hologic Notable Stakeholders
A Hologic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hologic often face trade-offs trying to please all of them. Hologic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hologic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephen MacMillan | Chairman, CEO and Pres | Profile | |
Jennifer Schneiders | President Solutions | Profile | |
Jan Verstreken | Regional President - Europe,Middle EastandAfrica(EMEA) and Canada | Profile | |
Karleen Oberton | CFO, Chief Accounting Officer | Profile | |
Mark Irving | VP Secretary | Profile | |
Paul Malenchini | Chief Officer | Profile | |
Peter Dunne | Senior Resources | Profile | |
Benjamin Cohn | Principal Chief Accounting Officer | Profile | |
Erik Anderson | Division Solutions | Profile | |
Kevin Thornal | Group Solutions | Profile | |
Karleen CPA | Chief Officer | Profile | |
Scott Christensen | Quality Chain | Profile | |
John JD | General Counsel | Profile | |
Elisabeth Hellmann | Sr Communications | Profile | |
John Griffin | General Counsel | Profile | |
Mike Kelly | Chief Affairs | Profile | |
Essex Mitchell | Chief Officer | Profile | |
Michael Watts | Corporate Relations | Profile | |
Ryan Simon | Vice Relations | Profile | |
Monica Berthelot | VP Staff | Profile | |
Diana SPHR | Senior Resources | Profile | |
Brandon Schnittker | Division Solutions | Profile | |
Anne Liddy | General Counsel | Profile |
About Hologic Management Performance
The success or failure of an entity such as Hologic often depends on how effective the management is. Hologic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hologic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hologic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.09 | 0.10 | |
Return On Capital Employed | 0.08 | 0.08 | |
Return On Assets | 0.05 | 0.04 | |
Return On Equity | 0.09 | 0.10 |
Please note, the imprecision that can be found in Hologic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hologic. Check Hologic's Beneish M Score to see the likelihood of Hologic's management manipulating its earnings.
Hologic Workforce Analysis
Traditionally, organizations such as Hologic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hologic within its industry.Hologic Manpower Efficiency
Return on Hologic Manpower
Revenue Per Employee | 570.6K | |
Revenue Per Executive | 175.2M | |
Net Income Per Employee | 111.8K | |
Net Income Per Executive | 34.3M | |
Working Capital Per Employee | 394.5K | |
Working Capital Per Executive | 121.1M |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.